Valuation: Haleon plc

Market Cap 28.92B 38.26B 33.99B 31.73B 54.54B 3,678B 55.05B 384B 149B 1,880B 144B 141B 6,035B P/E 2026 *
17.1x
P/E 2027 * 15.1x
Enterprise Value 35.82B 47.39B 42.11B 39.3B 67.56B 4,556B 68.19B 476B 184B 2,329B 178B 174B 7,475B EV / Sales 2026 *
3.15x
EV / Sales 2027 * 2.97x
Free-Float
98.46%
Yield 2026 *
2.46%
Yield 2027 * 2.72%

Last Transcript: Haleon plc

1 day+0.15%
1 week-4.20%
Current month-2.75%
1 month-8.19%
3 months-9.88%
6 months-11.96%
Current year-12.41%
1 week 324.8
Extreme 324.8
345.4
1 month 324.8
Extreme 324.8
350.1
Current year 317.8
Extreme 317.8
416.1
1 year 317.8
Extreme 317.8
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 58 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap. Importance
9/22/26 Buy 2,139 0.0000%
9/22/26 Buy 12,209 0.0001%
9/22/26 Buy

Chief Financial Officer

2,317 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%-4.20%-0.91%-3.74% 38.26B
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -0.67%-3.47%+23.37%+52.64% 373.54B
Weighted average by Cap. -0.59%-3.33%+28.77%+70.38%

Financials

2026 *2027 *
Net sales 11.38B 15.06B 13.38B 12.49B 21.47B 1,448B 21.67B 151B 58.57B 740B 56.54B 55.32B 2,375B 11.86B 15.69B 13.94B 13.01B 22.37B 1,508B 22.58B 157B 61.02B 771B 58.91B 57.64B 2,475B
Net income 1.72B 2.28B 2.03B 1.89B 3.25B 219B 3.28B 22.89B 8.87B 112B 8.56B 8.38B 360B 1.93B 2.56B 2.27B 2.12B 3.64B 246B 3.68B 25.65B 9.94B 126B 9.6B 9.39B 403B
Net Debt 6.9B 9.13B 8.11B 7.57B 13.02B 878B 13.14B 91.64B 35.51B 449B 34.28B 33.54B 1,440B 6.3B 8.34B 7.41B 6.92B 11.89B 802B 12B 83.71B 32.44B 410B 31.32B 30.64B 1,316B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-10-02 GBX 328.30 +0.15% 27,426,462
26-10-01 GBX 327.80 -2.90% 26,596,788
26-09-30 GBX 337.60 +0.15% 35,694,952
26-09-29 GBX 337.10 -0.91% 37,862,405
26-09-28 GBX 340.20 -0.73% 23,909,292
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.283GBP
Average target price
4.185GBP
Spread / Average Target
+27.47%

Quarterly revenue - Rate of surprise